Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/13/12/1862/347436/mdf308.pdf
Reference22 articles.
1. Chemotherapy and survival in patients with non-small cell lung cancer. A contrary view;Haskell;Chest,1991
2. Chemotherapy for advanced non-small cell lung cancer: how much benefit is enough?;Grilli;J Clin Oncol,1993
3. Polichemotherapy in advanced non-small cell lung cancer: a meta-analysis;Soquet;Lancet,1993
4. Chemotherapy in non-small-cell lung cancer: meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non-Small-Cell Lung Cancer Collaborative Group;Br Med J,1995
5. Mytomicin, ifosfamide, and cisplatin, in unresectable non-small cell lung cancer: effects on survival and quality;Cullen;J Clin Oncol,1999
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses;Antiviral Research;2011-09
2. Phase II Study of Weekly Gemcitabine and Vinorelbine for Children With Recurrent or Refractory Hodgkin's Disease: A Children's Oncology Group Report;Journal of Clinical Oncology;2009-03-20
3. Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer;Lung Cancer;2006-08
4. Lung cancer;Cancer Chemotherapy and Biological Response Modifiers Annual;2005
5. Gemcitabine (Gemzar®) in non-small cell lung cancer;Expert Review of Anticancer Therapy;2004-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3